Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogenetic technique for rapid evaluation of the entire genome with sub-megabase resolution. It allows for the comprehensive investigation of thousands and millions of genomic loci at once and therefore enables the efficient detection of DNA copy number variations (a.k.a, cryptic genomic imbalances). The development and the clinical application of array CGH have revolutionized the diagnostic process in patients and has provided a clue to many unidentified or unexplained diseases which are suspected to have a genetic cause. In this paper, we present three clinical cases in both prenatal and postnatal settings. Among all, array CGH played a major disc...
Abstract Background Array comparative genomic hybridization (CGH) is currently the most powerful met...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) i...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
Abstract Background Array comparative genomic hybridization (CGH) is currently the most powerful met...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) i...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
Abstract Background Array comparative genomic hybridization (CGH) is currently the most powerful met...
OBJECTIVE: To identify chromosomal imbalances by whole-genome microarray-based comparative genomic h...
Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) i...